New strategies for patenting biological medicines used in rheumatoid arthritis treatment
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2018.1502748
Abstract: ABSTRACT Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an inflammatory process, with a global prevalence ranging from 0.3% to 1%. The overall cost of RA drugs is estimated in $20 billion… read more here.
Keywords: new strategies; treatment; rheumatoid arthritis; patenting biological ... See more keywords